Elizabeth Miles Receives ESTRO 2025 Interdisciplinary Award

Sometimes, the most profound progress begins with a single question: What if we work together differently? For Dr. Elizabeth Miles, that question has fueled a career defined by boundary-breaking collaboration—one that has now earned her the Interdisciplinary Award at ESTRO 2025, one of the highest honors in the field of radiation oncology.

A Career Rooted in Partnership

Dr. Miles has long believed that the future of cancer care depends on dismantling silos and building bridges between disciplines. Whether it’s integrating the insights of medical physicists, clinical oncologists, radiobiologists, or therapists, she has always advocated for a unified approach to treating patients—not just the disease.

Her tireless efforts to lead and inspire multidisciplinary teams have made a real-world difference. From research labs to treatment rooms, Dr. Miles’s impact can be felt in every corner of oncology where science and compassion converge.

Honoring Interdisciplinary Excellence

In recognition of her trailblazing work, Dr. Miles received the Interdisciplinary Award at ESTRO 2025, held in Vienna, Austria. The award—bestowed by the European Society for Radiotherapy and Oncology (ESTRO)—honors individuals who have advanced radiation oncology through meaningful cross-disciplinary contributions. Past recipients include pioneers like Anthony Chalmers (2024) and Uulke van der Heide (2023). Dr. Miles now joins this prestigious list, representing the power of collaboration in driving change.

This year’s award feels especially poignant as it comes during a congress whose central theme is “Transformative Innovation Through Partnership.” A perfect reflection of Dr. Miles’s life’s work.

A New Era of Collaboration: OncoDaily x ESTRO

In another exciting step forward, OncoDaily announced its official partnership with ESTRO for this year’s congress. Under the banner “OncoDaily x ESTRO: Collaborating Live at ESTRO 2025!”, OncoDaily is offering real-time coverage, insights, and stories from the event—bringing the energy of the congress to a global audience.

Taking place from May 2–6, 2025, at the Messe Wien Exhibition & Congress Center, the ESTRO 2025 congress is a vital moment for the international radiation oncology community. It’s where innovation meets interaction, and where the brightest minds come together to shape the future of cancer treatment.

“We’re not just sharing research—we’re building a movement,” said one ESTRO delegate.

What Makes ESTRO 2025 So Pivotal?

• Core Mission: To embed radiation oncology more deeply in multidisciplinary cancer care and improve global access to high-value therapy.

• Program Highlights: Late-breaking trial results, audience-faculty exchanges, interdisciplinary science, and the “Young Track” for early-career professionals.

• Industry Impact: Features Europe’s largest radiation oncology exhibition.

• Global Goal: To connect, educate, and inspire professionals across healthcare systems and specialties.

A Legacy of Impact

Dr. Miles’s story isn’t just about awards or recognition. It’s about redefining what’s possible when we choose collaboration over competition, and shared knowledge over isolated expertise. Her journey exemplifies how the best care happens when diverse minds work together toward a common goal: better outcomes for every patient, everywhere.

She stands not only as a beacon of scientific innovation but also as a reminder that true progress in cancer care begins with partnership—the kind ESTRO 2025 and OncoDaily are now bringing to life on a global stage.

“Innovation thrives when we invite every voice to the table,” says Dr. Miles. “That’s how we build a future worth fighting for.”

As ESTRO 2025 continues to unfold, stay tuned to OncoDaily for the most trusted news, expert interviews, and exclusive behind-the-scenes coverage.

Mark your calendar for May 2–6, 2025, and don’t miss this pivotal moment in oncology history. Because the future of cancer care isn’t built in isolation—it’s built together.

Don’t miss a moment.

Whether you’re a researcher, clinician, patient advocate, or simply someone passionate about the future of cancer care—this is your community.

Follow OncoDaily on all platforms to stay connected, inspired, and informed.
Together, we’re building the conversations—and the collaborations—that move oncology forward.

Because the future of cancer care is already happening. Let’s be part of it—together.

By: Md Foorquan Hashmi, MD, Sr. Editor, OncoDaily: India Bureau